Drug Utilization Evaluation of High Alert Medications in Intensive Care Units of Tertiary Care Teaching Hospital
Introduction: The utilization of HAMs is crucial in emergency and intensive care departments, as they can cause a significant amount of damage to the patient and health care members if we could not follow the standard treatment guidelines. Drug utilization evaluation/review involves a comprehensive review of the patient’s prescription and medication data before, during, and after dispensing to ensure appropriate medication decision making and positive patient outcomes.
Objective: This study was taken up given finding the utilization patterns and rectifying the issues with the usage of high alert medications (HAMs) and improving their utilization.
Methodology: A cross-sectional study was conducted for 6 months at a south Indian tertiary care hospital. Treatment guidelines were prepared to compare the actual drug use. Data were collected both retrospectively and prospectively by patients and care taker’s interview, medication chart review, and discussion with prescribers and applied WHO DUE indicators to evaluate utilization patterns.
Results: Of 362 cases, 57.73 % were males/ and the majority geriatrics. Among all HAMs Insulin is frequently prescribed (34.5 %) and the costly drug is Enoxaparin. Generic names were used in writing prescriptions and parenteral formulations were mostly used. Around 9 ADRs were identified and managed, and a total of 133 moderate to severe Drug-Drug Interactions were found, of them, only 2 were actual.
Conclusion: With this study, we conclude that the use of HAMs was found to be appropriate as per the guidelines as we observed very few DRPs with the study drugs.
Keywords: HAM, DRP’s, DUE, ICU, DDD
 Preventing high-alert medication errors in hospital patients [internet]2019[updated 2015 may 11;cite2019 oct 03].https://www.americannursetoday.com/preventing-high-alert-medication-errors
 Saed H. Zyoud, Samar M. Khaled, Baraa M. Kawasmi, et al., Knowledge about the administration and regulation of high alert medications among nurses in Palestine: a cross-sectional study; BMC Nursing (2019) 18:11
 High-Alert Medications in Acute Care Settings[internet]2019[updated 2018 Aug 23].https://www.ismp.org/recommendations/high-alert-medications-acute-list.
 Ilse Truter; A Review of Drug Utilization Studies and Methodologies; Jordan Journal of Pharmaceutical Sciences, 2008, 1(2).
 What are Drug Utilization Reviews (DUR), (internet),2009, Extracted from The Academy of Managed Care Pharmacy’s Concepts in Managed Care Pharmacy.
 Shalini.S.Ravichandran. V, Mohanty. B.K et al., drug utilization studies; An overview, IJPSN, 3(1).2010 pp.803-811
 G. Parthasarathy, Karin NY fort –Hansen, Mila C Napata. A textbook of clinical pharmacy practice essential concepts and skills. 2nd edition. 2012. Universities press publications. pp. 447-460.High-Alert Medications in Acute Care Settings[internet]2019[updated 2018 Aug 23].https://www.ismp.org/recommendations/high-alert-medications-acute-list.
 Manjula Devi et.al, a study on prescribing pattern of high alert medications in the medical intensive care unit; IOSR Journal of dental and medical sciences (IOSR-JDMS); December. 2018 ; 17(12);pp 23-26
 Mitchel Kim et.al, older adults and high-risk medications administration in the emergency department; Drug Health Patient Saf. 2017; 9; 105-112
 Anitta Thomas et.al, Drug utilization pattern in adult medical intensive care unit of a tertiary care hospital; Chrismed journal of health and research; 6(1), pp35-38
 Murat sungur et.al, intensive care management of organophosphate insecticide poisoning; Critical care 2001, 5; pp 211-215.
 Christopher et.al, R The Role of Digoxin in the Treatment of Heart Failure Circulation; Heart Failure. 2008;1;pp 206-207.
 Andrea Rubboli et.al, Utilizing Enoxaparin in the management of STEMI; Vascular Health and Risk Management 3(5); pp 691-700
 Massi Benedetti et.al, Glimepiride in type 2 diabetes mellitus; a review of the worldwide therapeutic experience; ClinTher. 2003 Mar;25(3); pp; 799-816.
 Sanne G swinnen et.al, Insulin Therapy for Type 2 Diabetes; Diabetes Care. 2009 Nov;32(Suppl 2); pp; 253-259.
 Rob smith et.al; Midazolam for status epileticus ;AustPrescr. 2017 feb ; 40(1)’pp 23-25
 Hamzaouiet. al; Norepinephrine in septic shock: when and how much; CurrOpinCrit Care. 2017 Aug;23(4):pp:342-347
 MEDICATION-RELATED ISSUES/Alzpossible [internet]2007[Dec 5],https://alzpossible.org/medication-related-issues/
 Joseph T.Dipiro: AHFS Drug handbook: second edition: Springhouse Lippincott Williams and Wilkins publications: pp – 167-169, 399 - 403, 459 – 462, 577 – 578, 651 – 652, 818 – 821, 889 – 890.
 Aline Teotonio Rodrigues et al: Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital: Braz. J. Pharm. Sci.2017;53(1):e16109
 Maharani et.al, the Prescription pattern of patients admitted in the intensive care unit of a tertiary care hospital in Puducherry, India: a cross-sectional study; IJBCP; DEC 2017;6(12), 2822.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).